Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 30, 2022
High-affinity FcγRIIIa genetic variants and potent NK cell-mediated antibody-dependent cellular cytotoxicity (ADCC) responses contributing to severe COVID-19Hannes Vietzen, Vera Danklmaier, Alexander Zoufaly, et al.
Scientific Reports|May 16, 2023
A retrospective analysis of clinical features of patients hospitalized with SARS-CoV-2 Omicron variants BA.1 and BA.2Cristina Groza, David Totschnig, Christoph Wenisch, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 26, 2021
Whipple's disease diagnosed in a patient with suspected sarcoidosisDavid Totschnig, Tamara Seitz, Alexander Zoufaly, et al.
Wiener Klinische Wochenschrift|June 17, 2024
The effect of early remdesivir administration in COVID-19 disease progression in hospitalised patientsMoritz Platzer, David Totschnig, Mario Karolyi, et al.
BMC Infectious Diseases|April 21, 2020
Molecular diagnosis of autochthonous human anaplasmosis in Austria - an infectious diseases case reportWolfgang Hoepler, Mateusz Markowicz, Anna-Margarita Schoetta, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|March 29, 2022
[Diagnosis and treatment of COVID-19 in intensive care units]Wolfgang Hoepler, Marianna Traugott, Alexander Zoufaly, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 27, 2021
Deletion of the NKG2C receptor encoding KLRC2 gene and HLA-E variants are risk factors for severe COVID-19Hannes Vietzen, Alexander Zoufaly, Marianna Traugott, et al.
Viruses|May 27, 2023
Efficacy of Sotrovimab (SOT), Molnupiravir (MOL), and Nirmatrelvir/Ritponavir (N/R) and Tolerability of Molnupiravir in Outpatients at High Risk for Severe COVID-19Victoria Kauer, David Totschnig, Ferdinand Waldenberger, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 2024
Diagnostic potential of blood plasma longitudinal viscosity measured using Brillouin light scatteringJennifer Illibauer, Tamara Clodi-Seitz, Alexander Zoufaly, et al.
Viruses|October 27, 2022
SARS-CoV-2 Pre-Exposure Prophylaxis with Sotrovimab and Tixagevimab/Cilgavimab in Immunocompromised Patients-A Single-Center ExperienceDavid Totschnig, Max Augustin, Iulia Niculescu, et al.
Pageof 9